BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 36318207)

  • 1. Association of Gonadotropin-Releasing Hormone Analogue Use With Subsequent Use of Gender-Affirming Hormones Among Transgender Adolescents.
    Nos AL; Klein DA; Adirim TA; Schvey NA; Hisle-Gorman E; Susi A; Roberts CM
    JAMA Netw Open; 2022 Nov; 5(11):e2239758. PubMed ID: 36318207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone Mineral Density in Transgender Adolescents Treated With Puberty Suppression and Subsequent Gender-Affirming Hormones.
    van der Loos MATC; Vlot MC; Klink DT; Hannema SE; den Heijer M; Wiepjes CM
    JAMA Pediatr; 2023 Dec; 177(12):1332-1341. PubMed ID: 37902760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Children and adolescents in the Amsterdam Cohort of Gender Dysphoria: trends in diagnostic- and treatment trajectories during the first 20 years of the Dutch Protocol.
    van der Loos MATC; Klink DT; Hannema SE; Bruinsma S; Steensma TD; Kreukels BPC; Cohen-Kettenis PT; de Vries ALC; den Heijer M; Wiepjes CM
    J Sex Med; 2023 Feb; 20(3):398-409. PubMed ID: 36763938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Hip Bone Geometry During Gender-Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty.
    van der Loos MA; Hellinga I; Vlot MC; Klink DT; den Heijer M; Wiepjes CM
    J Bone Miner Res; 2021 May; 36(5):931-941. PubMed ID: 33507568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosocial Characteristics of Transgender Youth Seeking Gender-Affirming Medical Treatment: Baseline Findings From the Trans Youth Care Study.
    Chen D; Abrams M; Clark L; Ehrensaft D; Tishelman AC; Chan YM; Garofalo R; Olson-Kennedy J; Rosenthal SM; Hidalgo MA
    J Adolesc Health; 2021 Jun; 68(6):1104-1111. PubMed ID: 32839079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Back to the Future: Is GnRHa Treatment in Transgender and Gender Diverse Adolescents Only an Extended Evaluation Phase?
    Fisher AD; Ristori J; Romani A; Cassioli E; Mazzoli F; Cocchetti C; Pierdominici M; Marconi M; Ricca V; Maggi M; Vignozzi L; Castellini G
    J Clin Endocrinol Metab; 2024 May; 109(6):1565-1579. PubMed ID: 38099569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trajectories of Adolescents Treated with Gonadotropin-Releasing Hormone Analogues for Gender Dysphoria.
    Brik T; Vrouenraets LJJJ; de Vries MC; Hannema SE
    Arch Sex Behav; 2020 Oct; 49(7):2611-2618. PubMed ID: 32152785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuation of gender-affirming hormones in transgender people starting puberty suppression in adolescence: a cohort study in the Netherlands.
    van der Loos MATC; Hannema SE; Klink DT; den Heijer M; Wiepjes CM
    Lancet Child Adolesc Health; 2022 Dec; 6(12):869-875. PubMed ID: 36273487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth in Transgender/Gender-Diverse Youth in the First Year of Treatment With Gonadotropin-Releasing Hormone Agonists.
    Schulmeister C; Millington K; Kaufman M; Finlayson C; Kennedy JO; Garofalo R; Chan YM; Rosenthal SM
    J Adolesc Health; 2022 Jan; 70(1):108-113. PubMed ID: 34315674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental Healthcare Utilization of Transgender Youth Before and After Affirming Treatment.
    Hisle-Gorman E; Schvey NA; Adirim TA; Rayne AK; Susi A; Roberts TA; Klein DA
    J Sex Med; 2021 Aug; 18(8):1444-1454. PubMed ID: 34247956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A European Network for the Investigation of Gender Incongruence in adolescents.
    Boogers LS; Wiepjes CM; Staphorsius AS; Klink DT; Ciancia S; Romani A; Stolk THR; van den Boogaard E; Steensma TD; de Vries ALC; van Trotsenburg ASP; den Heijer M; Fisher AD; Cools M; Hannema SE
    J Sex Med; 2024 Mar; 21(4):350-356. PubMed ID: 38427555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgender Dependent Adolescents in the U.S. Military Health Care System: Demographics, Treatments Sought, and Health Care Service Utilization.
    Van Donge N; Schvey NA; Roberts TA; Klein DA
    Mil Med; 2019 May; 184(5-6):e447-e454. PubMed ID: 30325452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Puberty Assessment and Consideration of Gonadotropin-Releasing Hormone Agonists in Transgender and Gender-Diverse Youth.
    Lee JY
    Pediatr Ann; 2023 Dec; 52(12):e462-e466. PubMed ID: 38049185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuation of Gender-affirming Hormones Among Transgender Adolescents and Adults.
    Roberts CM; Klein DA; Adirim TA; Schvey NA; Hisle-Gorman E
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3937-e3943. PubMed ID: 35452119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones.
    Schagen SEE; Wouters FM; Cohen-Kettenis PT; Gooren LJ; Hannema SE
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4252-63. PubMed ID: 32909025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes Following Acute Residential Psychiatric Treatment in Transgender and Gender Diverse Adolescents.
    Silveri MM; Schuttenberg EM; Schmandt K; Stein ER; Rieselbach MM; Sternberg A; Cohen-Gilbert JE; Katz-Wise SL; Blackford JU; Potter AS; Potter MP; Sarvey DB; McWhinnie CM; Feinberg JE; Boger KD
    JAMA Netw Open; 2021 Jun; 4(6):e2113637. PubMed ID: 34152417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Pubertal Blockade at Tanner 2/3 With Psychosocial Benefits in Transgender and Gender Diverse Youth at Hormone Readiness Assessment.
    McGregor K; McKenna JL; Williams CR; Barrera EP; Boskey ER
    J Adolesc Health; 2024 Apr; 74(4):801-807. PubMed ID: 38099903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Quality of Life of Transgender and Gender-Diverse Children and Adolescents in Melbourne, Australia, 2017-2020.
    Engel L; Majmudar I; Mihalopoulos C; Tollit MA; Pang KC
    JAMA Netw Open; 2023 Feb; 6(2):e2254292. PubMed ID: 36729456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiating gender-affirming hormones for transgender and non-binary people: A qualitative study of providers' perspectives on requiring mental health evaluations.
    Stroumsa D; Minadeo LA; Maksutova M; Moravek MB; Stephenson R; Pfeiffer PN; Wu JP
    PLoS One; 2022; 17(8):e0271785. PubMed ID: 35980962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Media Coverage of Transgender and Gender Diverse Issues With Rates of Referral of Transgender Children and Adolescents to Specialist Gender Clinics in the UK and Australia.
    Pang KC; de Graaf NM; Chew D; Hoq M; Keith DR; Carmichael P; Steensma TD
    JAMA Netw Open; 2020 Jul; 3(7):e2011161. PubMed ID: 32721030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.